(Reuters) – U.S. drugmaker Amgen said on Thursday it will invest $1 billion in a second manufacturing facility in North Carolina, expanding its prior $550 million commitment to the region. The new facility, to be built in Holly Springs alongside Amgen’s existing site, will create 370 new jobs. The company did not immediately respond to […]
Health
Amgen to invest $1 billion in new North Carolina manufacturing site
Audio By Carbonatix
(Reuters) – U.S. drugmaker Amgen said on Thursday it will invest $1 billion in a second manufacturing facility in North Carolina, expanding its prior $550 million commitment to the region.
The new facility, to be built in Holly Springs alongside Amgen’s existing site, will create 370 new jobs.
The company did not immediately respond to a request for comment on what treatments it was planning to manufacture at the new site.
Amgen’s first Holly Springs facility supports both conventional and new technologies of production, allowing Amgen to make multiple products in the same plant, according to a regulatory filing.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Tasim Zahid)